Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Locatelli, Franco, Zugmaier, Gerhard, Rizzari, Carmelo, Morris, Joan D, Gruhn, Bernd, Klingebiel, Thomas, Parasole, Rosanna, Linderkamp, Christin, Flotho, Christian, Petit, Arnaud, Micalizzi, Concetta, Mergen, Noemi, Mohammad, Abeera, Kormany, William N, Eckert, Cornelia, Möricke, Anja, Sartor, Mary, Hrusak, Ondrej, Peters, Christina, Saha, Vaskar, Vinti, Luciana, von Stackelberg, Arend
Published in JAMA : the journal of the American Medical Association (02.03.2021)
Published in JAMA : the journal of the American Medical Association (02.03.2021)
Get full text
Journal Article
Real-World Evidence of the Use of Carfilzomib and Dexamethasone (Kd) By Lenalidomide-Refractory Status: An Interim Analysis from a Prospective Observational Study
Leleu, Xavier, Caers, Jo, Gamberi, Barbara, Söhne, Maaike, Heibl, Sonja, Suzan, Florence, Mohammad, Abeera, Wetten, Sally, Terpos, Evangelos
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse
Thomas, Xavier, Rijneveld, Anita W, Fracchiolla, Nicola, Šálek, Cyril, Spyridonidis, Alexandros, Chiaretti, Sabina, Alam, Naufil, Pezzani Grueter, Isabella, Mohammad, Abeera, Kormany, William, Kreuzbauer, Georg, Rambaldi, Alessandro
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Real-World Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients with at Least One Prior Therapy across 10 European Countries and Israel
Terpos, Evangelos, Slama, Borhane, Zambello, Renato, Badelita, Sorina Nicoleta, Katodritou, Eirini, Caers, Jo, Kühr, Thomas, Suzan, Florence, Mohammad, Abeera, Wetten, Sally, Leleu, Xavier
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Real-World Evidence of the Use of Approved Carfilzomib Regimens in Patients Previously Exposed or Refractory to Lenalidomide: Updated Results from a Prospective Observational Study
Leleu, Xavier, Slama, Borhane, Zambello, Renato, Badelita, Sorina Nicoleta, Katodritou, Eirini, Caers, Jo, Kühr, Thomas, Suzan, Florence, Mohammad, Abeera, Wetten, Sally, Terpos, Evangelos
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Real-world use of carfilzomib among multiple myeloma patients with at least one prior therapy
Terpos, Evangelos, Gamberi, Barbara, Caers, Jo, Söhne, Maaike, Heibl, Sonja, Suzan, Florence, Szabo, Zsolt, Mohammad, Abeera, Wetten, Sally, Leleu, Xavier
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Real-World Evidence of the Use of Carfilzomib and Dexamethasone According to Age Subgroup: An Interim Analysis From a Prospective Observational Study
Terpos, Evangelos, Leleu, Xavier, Gamberi, Barbara, Söhne, Maaike, Heibl, Sonja, Suzan, Florence, Mohammad, Abeera, Wetten, Sally, Caers, Jo
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article
Real-World Use of Carfilzomib Therapy Among Patients With Existing Cardiovascular Medical History: An Analysis of a Prospective Observational Study
Caers, Jo, Leleu, Xavier, Gamberi, Barbara, Söhne, Maaike, Heibl, Sonja, Suzan, Florence, Mohammad, Abeera, Wetten, Sally, Terpos, Evangelos
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.10.2019)
Get full text
Journal Article